Basel Medical Group Ltd
BMGL
$4.45
$0.040.91%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.54M | 1.70M | 1.87M | 1.59M | 1.32M |
| Total Depreciation and Amortization | 392.30K | 383.00K | 373.20K | 390.80K | 407.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.10K | 106.80K | 280.00K | 133.00K | -13.40K |
| Change in Net Operating Assets | -1.60K | -631.50K | -1.27M | -531.40K | 203.40K |
| Cash from Operations | 1.86M | 1.56M | 1.25M | 1.58M | 1.91M |
| Capital Expenditure | -5.80K | -6.40K | -7.00K | -5.80K | -4.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.80K | -6.40K | -7.00K | -5.80K | -4.60K |
| Total Debt Issued | 1.42M | -3.36M | -8.15M | -4.07M | 0.00 |
| Total Debt Repaid | -2.92M | 1.54M | 6.01M | 1.53M | -2.94M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -267.60K | -133.60K | 400.00 | 400.00 | 400.00 |
| Cash from Financing | -1.31M | -1.46M | -1.60M | -1.88M | -2.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 545.00K | 96.60K | -355.70K | -305.50K | -254.90K |